Naja-comp.
Drughomeopathic remedy
Other names: Naja compositum
NCT Number: NCT01048411
The homeopathic remedy 'naja-comp' will improve functional outcome measured by the Barthel-Index.
The homeopathic remedy 'naja-comp' will decrease complications during geriatric rehabilitation measured by rate of unplanned discharge to hospital.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
KWA Stift Rottal, Bad Griesbach, Bavaria, Germany
Secondary outcome for functional improvement are Scandinavian Stroke Scale, 4D+S-Scale and Timed-Up&Go-Test.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
homeopathic remedy
Other names: Naja compositum
s.c. injection of NaCl-solution three times a week
Other names: NaCl 0.9%
Time frame: baseline, 21st day of rehabilitation
Time frame: until day 21 of rehabilitation
Time frame: baseline, 21st day of rehabilitation
University of Erlangen-Nürnberg Medical School
Other
Multicenter Randomized Controlled Trial to Investigate the Influence of the Homeopathic Remedy 'Naja-comp' on Stroke Therapy in Geriatric Rehabilitation
Acronym: naja-comp
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT04685408
Brain Diseases, Cardiovascular Diseases
Kampala, Uganda
View Trial DetailsNCT05016531
Brain Diseases, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07751224
Brain Diseases, Cardiovascular Diseases
Ho Chi Minh City, Vietnam
View Trial Details